KDR and neoplasm: The possibility that VEGFR-2 on GSLCs may be activated by ligand present in the tumor environment was confirmed in the xenograft tumors initiated by GSLCs in which tumor cells expressed high levels of both VEGFR-2 and VEGF (Fig. 4E).